Announcements Trials

Browse Landscape

Phase

Phase 1 8 Phase 1/2 6 Phase 2 5 Phase NA 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Head and Neck Neoplasms 1 Glioblastoma 1

Interventions

Temozolomide 2 trametinib 1 pembrolizumab 1 dabrafenib 1 Restraint, Physical 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Outcome Assessment, Health Care 1 Observational Studies as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Glioblastoma × Radiosurgery × Clear all

NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡